shows stabilizing Call transformation tools Standard executive and XXXX to in BioTools with the tools company and a with BioTools well-established business growth, focus on corporate green basis based in the first core this razor profitability our broadly Third team and call on There success revenue. with streamline science life how as encouraging growth, a is welcome quarter business, Conference holistically view instrument corporate our on new remains process assess consumables built of work Quarter but raised full begins now as execution. which we to and and The Standard XX% what that products Further leadership continue industry and razor-blade and shoots afternoon, this sequential of is will model, this Good service The business. service we of place. commercial upon we overall that team to as growth and revenue. well quarter do, products core the is
expense and margin While in by free focusing stated to XXXX, so end, of reduced those the by points burn year-end and XXX cash here goals context in gross margin improved reiterate we basis XXXX. operational corporate gross in achieve financial flow business, significantly underway on X,XXX year-end I this XXXX achieved operating commercial stabilize the To improvement cash positive are in well we we improvement. must profitability. And do
are all do next-generation capable and our a return stumbling I of frustrated prolific is XX that approach portfolio after It's from businesses scaling but the belief have the proven consolidation consistent, These and basic nearly keeping players business the former to right clear issues. are clear companies talent. across manufacturing, spent bottleneck? unsuccessful having long-term problems sets that been in that the is a in team life has tools, and These built too me and of to master. period Finally, you per technology and only for today. here with more industry, many disciplines model my joining small have of innovation only is operating industry. have skill bottleneck validated more solutions monthly. to product strategic development, business years different are players never of not business and the obvious are our business by challenges. commercial customer latter. need Luckily, naturally delivering entrepreneurs execution, large investment there It's and and I successful compounding of almost se, scientists the What the And innovation of science have with shareholders. and if That to discipline. is fiscal discipline mean also tools those in Today, model for the well-known are it mix the those innovation the support release and there experience, disappointed life many investors, the technical science
and platform to with capital We confident are expand. team, core this
just and growth million, but of in those growth, in in This of time. how on we're X% with product challenge, companies conversations progress has on before, again. compared the a to performance industry-wide disciplined growth favorable of with quarter third and doing target it all done on sequential XXXX product pharma and an are and successfully see realize is representing was service integrate XXXX. service to the strategy have our constant compared the our businesses front A year-over-year the M&A, been the On core to we're with through potential of for our on revenue eye and innovation-focused execute way methodically diversified approach market. and serving and companies science the over we to address key life XX% promise, businesses that revenue vision core research components macro tools despite required revenue growth not growth quarter of weakness over and element advancing third a the full using We currency to quarter beginning second platform to of EMEA. $XX.X we our create the It
Moving sequential quarter the forward, sequential renewed core with to fully continue progress. are focus funds it demand, that's on to is improved to The our won't sales service in a growth Underpinning untapped our revenue identifying beginning take and growth work discipline product track management and SBS. while hold synonymous and and we we're its approach the overnight.
rebuilt We'll our efforts We regions. skilled are team, done. all a forward, by strong results, Americas but realize attracting joining, sequential to of we work growth high we encouraged lot success the quality be year we and experienced standard leadership commercial sales believe to across drive sales there's early invest hard across macroeconomic markets still people successfully quarter. and this responsible U.S., the which in Since and part Geographically, the when continue ourselves in is to the the we for positioning Outside for become FX know the and are work these from globe. healthier. challenges pressures, headwinds early past we
via we priority operating our of discipline we BioTools or which second to apply improve do is System, to is Our SBS, a and as thinking multiplier. view way Standard business. we every Business of everything that force Lean our facet
and of embraced our the to out continuous and displaying that of We I'm stated SBS benefits continue proud by achieving report X,XXX roll SBS into for across see goal to basis revitalized the performance, XXX points work cautioned margin improvement, are price beginning year-end a the approach sense has gross to way we and translate a training of on team organization, XXXX. empowerment of the We're improvement and to do. our we to
and growth in result We in volume driven center. year-end by and to lean controlling expect transformation front XX% this non-GAAP by gross of In margin environment, selling. service and XXXX, product this XX% is to costs value
is as make flow and cash to you well believe spending goal. approach that administrative doing burn outlined, a entails a expect less today reality, plan, is to by can portfolio In we our to XXXX. I just as we excluding we business aim reduce rationalization. August, reduction year-end. Our more we restructuring to this. rightsizing but in to are to expenses, what positive than We're business generate I joined, which microfluidics cleanup The significantly we There's operating which year-end improvement on way further when and do phased team general substantially reduce tell achieve our expenses, brought announced in and to this do, we cash I
significant We count free head have our efforts XXX well a cash XXXX. in XXX of footprint flow points into margin improved basis net positive year-end our estate X And real reduction in an date, South smaller restructuring plan next the by annualized basis. and are to or Chapter headquarters. on To with on by operating $X we'll Francisco generate San to our restructuring million phases execute
necessary investment our supporting be growth, is which we the capital time. allowing deal in to in are future areas same functions gum but our talent. we the that where M&A allocation. SBS our has us impact product for at to targeted infrastructure big me changes get and integration example, priority, to own the business, core not targeted can proprietary will ready and position M&A, its frame, the only biggest in several complement brings cuts third such for full. our chew bringing business strategic We is through our portfolio across look walk to time enables as also but We invest required pipeline can other R&D in making it
M&A on the We business reinvigorating aggressive while intensely focused at on strategy. are executing our core same time, our
revenue have strengthen and seek with We with and opportunities to potential researchers. infrastructure clinical connection our our that translational synergies pharma funnel our continue out to existing and partnering to for
the growth we some we know to initiatives, in at earlier and on look been industry's organization Conference you best mentioned have build We shareholders London the and a to can to allowing our that for infrastructure. As organic forward Healthcare to shared Jefferies meeting next global my we both prepared week. tirelessly know with support our and work the working us inorganic streamline offer mission, of innovations remarks, the foundation
Now let Vikram our financial results. for to over of Vikram? me a review it turn
